Cargando…
Mediators of SARS-CoV-2 entry are preferentially enriched in cardiomyocytes
BACKGROUND: The coronavirus disease 2019 (COVID-19) has spread rapidly around the world. In addition to common respiratory symptoms such as cough and fever, some patients also have cardiac injury, however, the mechanism of cardiac injury is not clear. In this study, we analyzed the RNA expression at...
Autores principales: | Yang, Jing, Chen, Tan, Zhou, Yafeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781406/ https://www.ncbi.nlm.nih.gov/pubmed/33397514 http://dx.doi.org/10.1186/s41065-020-00168-4 |
Ejemplares similares
-
MicroRNAs targeting the SARS-CoV-2 entry receptor ACE2 in cardiomyocytes
por: Lu, Dongchao, et al.
Publicado: (2020) -
SARS-CoV-2 in cardiomyocytes
por: Finsterer, Josef
Publicado: (2021) -
Intermediates in SARS-CoV-2 spike–mediated cell entry
por: Marcink, Tara C., et al.
Publicado: (2022) -
Tumor Necrosis Factor-Alpha Exacerbates Viral Entry in SARS-CoV2-Infected iPSC-Derived Cardiomyocytes
por: Lee, Chiu-Yang, et al.
Publicado: (2021) -
Cell entry by SARS-CoV-2
por: Peng, Ruchao, et al.
Publicado: (2021)